The name says it all: Contract Pharmacal Corp. (CPC) is a full-service contract research organization serving pharmaceutical companies, retailers, and wholesalers worldwide. CPC manufactures dietary supplements, a variety of over-the-counter medications, and private label and generic prescription drugs. The company's prescription portfolio consists of mostly of prenatal and multi-vitamins, as well as urinary tract infection treatments. Production capabilities also include manufacturing tablets, gelatin capsules, softgels, and liquids that can be packaged in bottles, cans, blister pouches, and cartons. CPC (in business since 1971) is owned and operated by CEO Matt Wolf and the founding Wolf family.
Along with the more than four billion tablets, softgels, and powdered products CPC produces each year, the company also performs services such as granulation, blending, compression, and encapsulation at three manufacturing plants and one packaging facility in New York.
The company also handles some 300 active pharmaceutical ingredients (API). Additionally, CPC makes point-of-sale displays and provides marketing services.
Pharmaceutical customers include AmerisourceBergen, Bayer, and GlaxoSmithKline. Among CPC's retail customers are CVS, Kinray, and Walgreens.